Jingrong Jean Cui, Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 38,100 shares at $59.03 ($2.2M) on 2020-01-29, disclosed to the SEC on 2020-01-29.
Open-market sale of $2.2M TPTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.82 | 1,599 | $91K | 4.1% |
| 2 | $56.82 | 1,599 | $91K | 4.1% |
| 3 | $57.71 | 3,800 | $219K | 9.9% |
| 4 | $58.40 | 1,601 | $93K | 4.2% |
| 5 | $58.40 | 1,601 | $93K | 4.2% |
| 6 | $58.18 | 4,068 |
| $237K |
| 10.7% |
| 7 | $58.18 | 4,068 | $237K | 10.7% |
| 8 | $58.62 | 2,932 | $172K | 7.7% |
| 9 | $58.62 | 2,932 | $172K | 7.7% |
| 10 | $58.39 | 3,399 | $198K | 8.9% |
| 11 | $58.39 | 3,399 | $198K | 8.9% |
| 12 | $59.03 | 3,501 | $207K | 9.3% |
| 13 | $59.03 | 3,501 | $207K | 9.3% |
| 14 | $59.72 | 100 | $6K | 0.3% |
| Total | $58.30 avg | 38,100 | $2.2M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |